GORE® EXCLUDER® Iliac Branch Endoprosthesis Exceeds 1,000 Implants Worldwide
W. L. Gore & Associates, Inc. (Gore) today announced that the GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe . The device is currently commercially available in Europe and Australia, in clinical trial in the US, and available through special access in Canada.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151117005075/en/
The device is the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. Used in conjunction with GORE® EXCLUDER® AAA Endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries — the iliac branch device is built on Gore’s proven technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft and nitinol stent combination.
"With traditional EVAR techniques, preserving flow into the internal iliac artery in patients with common iliac artery aneurysms can be very difficult. The availability of a complete EVAR system permitting preservation of pelvic blood flow using an iliac branch device was previously non-existent,” said Darren Schneider, MD, Chief of Vascular and Endovascular Surgery at the Weill Cornell Medical College. “Now, with so many examples of positive outcomes from all over the globe, it is exciting to see more patients have access to the clinical benefits offered by this device."
The GORE EXCLUDER Iliac Branch Endoprosthesis provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a treatment range of 6.5-25 mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16 Fr introducer sheath for the iliac branch component, and a 12 Fr flexible, reinforced introducer sheath for the internal iliac component.
“Our dedicated components for iliac artery repair continue to provide a complete low profile system for managing common iliac artery aneurysms,” said Ryan Takeuchi, Aortic Business Unit Leader at Gore. “Because of the various configurations, this innovative technical solution is available for choosing the right product for the best individual treatment of the patient.”
The GORE EXCLUDER Iliac Branch Endoprosthesis is part of the growing family of GORE EXCLUDER Device and thoracic Conformable GORE® TAG® Device products that share a mission to effectively treat aortic aneurysms through minimally invasive means, backed by Gore’s highly rated clinical support team and comprehensive educational offerings.
Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780
ABOUT W. L. GORE & ASSOCIATES
At Gore, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the US “100 Best Companies to Work For” lists since the rankings debuted in 1984.
Products listed may not be available in all markets. GORE®, EXCLUDER®, and TAG® are trademarks of W. L. Gore & Associates. AU0711-EN1 NOVEMBER 2015
Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1 312-997-2436
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
AURAK15.12.2018 11:51 | Pressemeddelelse
AURAK Gains SACSCOC Accreditation
KRAMER-LEVIN14.12.2018 18:44 | Pressemeddelelse
Lehman Brothers Treasury Announces Plans for Partial Wind-Down
MA-TAKEDA-PHARMACEUTICAL14.12.2018 18:02 | Pressemeddelelse
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD
FL-POTNETWORK-HOLDINGS14.12.2018 16:44 | Pressemeddelelse
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules
HENLEY-&-PARTNERS14.12.2018 15:02 | Pressemeddelelse
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth
BOEHRINGER-INGELHEIM14.12.2018 10:09 | Pressemeddelelse
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum